KEGG Queryv1.0.0

Identify existing drugs that target pathways implicated in rare diseases by querying KEGG disease-drug associations. This accelerates discovery of new therapeutic uses for approved drugs, reducing time and cost.

Retrieve enzyme genes and compounds from KEGG pathways to design synthetic metabolic routes for producing valuable biochemicals. Used for strain engineering in industrial biotechnology.

Cross-reference patient genetic variants with KEGG drug target genes to predict drug efficacy and adverse reactions. Enables tailored therapy selection in clinical settings.

Analyze KEGG pathway gene sets and compound interactions to model disease mechanisms. Used for hypothesis generation in academic labs studying complex diseases like cancer or diabetes.

Pre-screen drug candidates for potential metabolic interactions by querying KEGG drug metabolism pathways and DDI data. Helps flag safety issues early in drug development.

Offer KEGG query capabilities as a subscription-based API integrated into drug discovery suites. Clients pay per API call or monthly tier, targeting pharma and biotech companies.

Provide expert services to interpret KEGG pathway data for client-specific research questions, such as target identification or disease mechanism elucidation. Charge per project or hourly.

License enriched KEGG-derived datasets (e.g., drug-target-pathway matrices) to bioinformatics companies and research institutions. Revenue from one-time data sales or annual subscriptions.